The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy
- Sponsor
- Center of Food and Fermentation Technologies
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Evaluation of blood lipid profile
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this dietary intervention is to study the effects of dietary fibers on the gut microbiota and use yoghurt as the carrier.
Hypothesis 1: Intake of dietary fibers improves the blood lipid profile of the participants.
Hypothesis 2: Intake of dietary fibers stabilizes the gut microbiome (e.g., low diversity) of the participants, improves gut health and normalizes gastrointestinal function and bowel habits.
Detailed Description
The study design is a parallel randomized, prospective, pre-post intervention trial. The main goal of this study is to investigate the effect of the dietary fibers in an unsweetened yoghurt. Fermented dairy products have naturally a very low dietary fiber content, but such products can be supplemented with variety of dietary fibers and promote the growth of beneficial gut bacteria. Also, as fermented milk products contain live bacteria, it is possible that prebiotic fibers could support the growth of the starter-culture based strains in the human gut. PRE-STUDY EVALUATION AND TESTING 1. Complete pre-study questionnaire 2. Complete orientation to the study and provide voluntary consent to join the study 3. Collection of coded intervention products, sampling supplies, and instructional materials 0-WEEK QUESTIONNAIRE AND LABORATORY VISIT 1. Record food intake and gastrointestinal function for 3 days 2. Collect health data and provide a 3-day food frequency questionnaire 3. Provide a stool and blood sample at the laboratory 2-WEEK QUESTIONNAIRE AND LABORATORY VISIT 1. Record food intake and gastrointestinal symptoms for 3 days 2. Collect health data and provide a 3-day food frequency questionnaire 3. Provide a stool and blood sample at the laboratory BLOOD SAMPLE ANALYSES 1. Provide the blood sample at the laboratory in the morning in an overnight fasted state. DIETARY INTERVENTION 1. Daily intake of a test or control product for two weeks.
Investigators
Madis Jaagura
Project Manager
Center of Food and Fermentation Technologies
Eligibility Criteria
Inclusion Criteria
- •Age 25-55
- •Normal bowel function
- •Regular consumer of dairy products, willing to consume dairy products daily for 2 weeks
- •Ability to provide a signed written informed consent
- •Willing to provide stool and blood specimens 2 times over the 2-week study period
Exclusion Criteria
- •Diagnosed history of chronic diseases including coronary heart disease, stroke, cancer, type 1 or 2 diabetes mellitus, inflammatory bowel disease, gastritis, autoimmune disease, or rheumatoid arthritis
- •Medication: statins, blood pressure medications, antidepressants, other prescription medications
- •History of bariatric operation, removal of the gallbladder.
- •Food allergies, lactose intolerance
- •Recent (previous 3 months) use of antibiotics
- •Intake of highly dosed pre- or probiotics 2 weeks prior and during the study
- •Current pregnancy or breastfeeding
- •Volunteers showing previously unrecognized illness will also be excluded
- •Individual unable to give informed consent
Outcomes
Primary Outcomes
Evaluation of blood lipid profile
Time Frame: 14 days
Triglycerides, total cholesterol, HDL-cholesterol, LDL-cholesterol pre- and post-dietary intervention in plasma (mmol/L).
Evaluation of the intestinal microbiota
Time Frame: 14 days
Fecal microbiota analysis based on the 16S rRNA sequencing pre- and post-dietary intervention.
Evaluation of blood glucose levels
Time Frame: 14 days
Fasting glucose pre- and post-dietary intervention in plasma (mmol/L).
Secondary Outcomes
- Evaluation of the defecation timing(14 days)
- Evaluation of the stool form(14 days)
- Evaluation of the blood vitamin D status(14 days)
- Evaluation of the defecation frequency(14 days)
- Evaluation of the gastrointestinal symptoms(14 days)